Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged vs Standard Infusion Meropenem in Pediatric Sepsis
NCT07122596Phase 4Completed
- Sponsor
- PNS Shifa
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of meropenem in sepsis, bacterial infection, sponsored by PNS Shifa. Started Apr 2024; status: completed.
02
Drugs
meropenem
03
Conditions
sepsisbacterial infection
Beyond the preview
Go deeper on NCT07122596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07122596.